Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**WEE1 pseudogene 1 (WEE1P1)** is a non-functional pseudogene related to the WEE1 G2 checkpoint kinase gene. Unlike the functional WEE1 kinase, which plays a crucial role in cell cycle progression and is a therapeutic target in oncology, WEE1P1 does not encode an active protein, has no established molecular function, and is not considered a receptor, enzyme, transporter, or other therapeutic target. Key points: - **WEE1P1** is a pseudogene—a DNA sequence similar to WEE1 but incapable of coding for a functional molecule. - **WEE1** (not WEE1P1) is a serine/threonine kinase, a critical cell cycle regulator and drug target in cancer therapy[2][3][1][7]. - No evidence indicates **WEE1P1** has any therapeutic, biological, or molecular relevance; it should not be considered a valid target. Important correction: If your intention was to identify the molecular target related to cell cycle control, refer to **WEE1 G2 checkpoint kinase (WEE1)**, not WEE1P1. WEE1 itself is an established drug target—WEE1P1 is not[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WEE1 pseudogene 1 (WEE1P1).